Company Overview of University of Oxford

University of Oxford Presents at World Stem Cell & Regenerative Medicine Congress, May-21-2013 09:10 AM. Venue: Victoria Plaza, London, United Kingdom. Speakers: John Krebs, Principal of Jesus College.

University of Oxford Presents at FT Global Pharmaceuticals and Biotechnology Conference 2012, Dec-04-2012 02:10 PM. Venue: Grange Tower Bridge Hotel, London, United Kingdom. Speakers: John Bell, Regius Professor of Medicine, Government Advisor on UK Life Sciences Strategy.

MindChild Medical, Inc. and University of Oxford announced the signing of a Sponsored Research Agreement for the development of innovative signal processing algorithms for use with the MERIDIAN(TM) non-invasive fetal heart monitor. MindChild previously announced clearance for its Pre-Marketing Notification (510(k)) from the US Food and Drug Administration (FDA) for the MERIDIAN(TM) non-invasive fetal heart monitor. MindChild anticipates entering the US market with MERIDIAN now that it has received the FDA clearance. Additional pre-market regulatory filings are anticipated during 2013. The Sponsored Research Agreement will be managed by Gari Clifford, PhD. Dr. Clifford is a member of the faculty at the University of Oxford in the Department of Engineering Science where Dr. Clifford is a University Lecturer and runs the Intelligent Patient Monitoring Group at the Institute of Biomedical Engineering (IBME), University of Oxford. Dr. Clifford is also the Director of the Centre for Doctoral Training in Healthcare Innovation, a major UK government funded centre for teaching translational biomedical engineering. Previously, Dr. Clifford held the position of Principal Research Scientist in the Laboratory for Computational Physiology at the Harvard-MIT Division of Health Sciences. Dr. Clifford received his PhD in Neural Networks and Biomedical Engineering from Oxford University.